{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:32:12Z","timestamp":1789561932874,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Gastric cancer (GC) remains a major challenge due to its high mortality and morbidity, despite extensive research. Dysregulated host immunity plays a critical role in carcinogenesis, particularly among susceptible cohorts. In the gastric mucosa of GC patients, a reduction in IL-34 and TAM1, accompanied by an increase in TAM2 <jats:italic>via<\/jats:italic> M-CSF, enhances Th2 cell function, reduces pro-inflammatory activity, and elevates anti-inflammatory responses. Consequently, TAM2 acts in both paracrine and autocrine manners to polarize and boost TAM2, creating a tumour-favourable microenvironment that supports GC progression. High levels of TAM2, observed during advanced GC stages, suppress gastric IL-34 production, further promoting GC development. In contrast, IL-35, a cytokine involved in immune regulation and suppression, is produced by activated T cells and\/or B cells in the affected gastric mucosa. Persistent <jats:italic>H. pylori<\/jats:italic> infection in GC tissues is associated with significant infiltration of IL-35-producing B cells and regulatory T cells (Tregs), which enhance the immunosuppressive and pro-tumour microenvironment by disrupting the local immune balance. Upregulated mucosal IL-35 promotes the polarization of TAM2 and Tregs while suppressing TAM1 cells, fostering a tumour-friendly environment that allows transformed gastric mucosal cells to evade immune surveillance, particularly in chronic <jats:italic>H. pylori<\/jats:italic>-infected patients. This cascade enhances proliferation and invasion while suppressing differentiation and apoptosis of GC cells. Together, the differential regulation of these cytokines creates an environment that supports cancer progression and resistance to therapy. Targeting the IL-34 and IL-35 pathways may offer a novel therapeutic strategy for improving outcomes in GC patients.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1559508","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:35:13Z","timestamp":1746768913000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The distinct role of IL-34 and IL-35 in gastric cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhiyun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04196.x","article-title":"Accuracy of a new ultrafast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients","volume":"31","author":"Vaira","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.5230\/jgc.2023.23.e40","article-title":"Worse survival of patients with T1 stage II gastric cancer following radical gastrectomy","volume":"23","author":"Lee","year":"2023","journal-title":"J Gastric Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-566","article-title":"Expression profile and prognostic role of sex hormone receptors in gastric cancer","volume":"12","author":"Gan","year":"2012","journal-title":"BMC Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/459810","article-title":"Helicobacter pylori\u2013a Nobel pursuit","volume":"22","author":"Marshall","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v8.i2.147","article-title":"Role of Helicobacter pylori in gastric cancer: Updates","volume":"8","author":"Khatoon","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12885-015-1099-y","article-title":"Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7927054","article-title":"The role of gastric mucosal immunity in gastric diseases","volume":"2020","author":"Nie","year":"2020","journal-title":"J Immunol Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800827","article-title":"From cancer immune surveillance to cancer immunoediting: birth of modern immuno-oncology","volume":"201","author":"Fridman","year":"2018","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v14.i1.216","article-title":"Immune evasion mechanisms and therapeutic strategies in gastric cancer","volume":"14","author":"Ma","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1154370","article-title":"Discovery of a cytokine and its receptor by functional screening of the extracellular proteome","volume":"320","author":"Lin","year":"2008","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344365","article-title":"Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells","volume":"44","author":"Wang","year":"2014","journal-title":"Eur J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.11.001","article-title":"Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia","volume":"37","author":"Greter","year":"2012","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1455231","article-title":"Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor","volume":"258","author":"Pandit","year":"1992","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nri3087","article-title":"Studying the mononuclear phagocyte system in the molecular age","volume":"11","author":"Chow","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.1.111","article-title":"Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects","volume":"99","author":"Dai","year":"2002","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"22239","DOI":"10.1038\/s41598-020-79312-z","article-title":"Effect of IL-34 on T helper 17 cell proliferation and IL-17 secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1042\/CS20150176","article-title":"Interleukin 34: a new modulator of human and experimental inflammatory bowel disease","volume":"129","author":"Zwicker","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.immuni.2024.08.015","article-title":"Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation","volume":"57","author":"Nian","year":"2024","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s42358-022-00279-8","article-title":"CD19(+)CD24(high)CD27(+) B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients","volume":"62","author":"Xiong","year":"2022","journal-title":"Adv Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu528","article-title":"Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis","volume":"54","author":"Nakano","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108938","article-title":"Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis","volume":"110","author":"Feng","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00472","article-title":"Interleukin-35 suppresses antiviral immune response in chronic hepatitis B virus infection","volume":"7","author":"Shao","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgy136","article-title":"Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells","volume":"39","author":"Hao","year":"2018","journal-title":"Carcinogenesis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/228620a0","article-title":"Cooperation of immune lymphoid cells with macrophages in tumour immunity","volume":"228","author":"Evans","year":"1970","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","article-title":"Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease","volume":"54","author":"Mulder","year":"2021","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.09.004","article-title":"Targeting tumor associated macrophages: The new challenge for nanomedicine","volume":"34","author":"Andon","year":"2017","journal-title":"Semin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13578-020-00454-8","article-title":"Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis","volume":"10","author":"Liu","year":"2020","journal-title":"Cell Biosci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-6","article-title":"Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study","volume":"13","author":"Cataldo","year":"2013","journal-title":"BMC Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41420-020-00350-7","article-title":"Macrophages produce and functionally respond to interleukin-34 in colon cancer","volume":"6","author":"Franze","year":"2020","journal-title":"Cell Death Discov"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1431495","article-title":"The role of IL-37 in gastrointestinal diseases","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051787","article-title":"The role of IL-38 in intestinal diseases - its potential as a therapeutic target","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7150\/thno.50683","article-title":"The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis","volume":"11","author":"Munoz-Garcia","year":"2021","journal-title":"Theranostics"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1282176","article-title":"The role of macrophages in gastric cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0163-7258(91)90077-y","article-title":"Macrophage-derived angiogenesis factors","volume":"51","author":"Sunderkotter","year":"1991","journal-title":"Pharmacol Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010710","article-title":"IL-35-producing B cells in gastric cancer patients","volume":"97","author":"Wang","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i28.3071","article-title":"Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects","volume":"24","author":"Bravo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202535","article-title":"Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13005","article-title":"IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1","volume":"10","author":"Li","year":"2020","journal-title":"FEBS Open Bio"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1384548","article-title":"Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes","volume":"15","author":"Yuan","year":"2024","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00262-019-02440-7","article-title":"Interleukin-38 in colorectal cancer: a potential role in precision medicine","volume":"69","author":"Chen","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.7.2845","article-title":"IL-35 over-expression is associated with genesis of gastric cancer","volume":"16","author":"Fan","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13403","article-title":"Serum level of interleukin-35 as a potential prognostic factor for gastric cancer","volume":"17","author":"Gu","year":"2021","journal-title":"Asia Pac J Clin Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1559508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:35:14Z","timestamp":1746768914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1559508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2025.1559508"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1559508","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"article-number":"1559508"}}